Situation Report: Mpox Cases Declining Globally
Share this article
Renaming to Mpox
NETEC is in the process of updating its web pages with the term “mpox” to reduce stigma and other issues associated with prior terminology. This change is aligned with the World Health Organization decision.
A Decline in Global Mpox Cases
On September 7, the World Health Organization reported that mpox cases globally had declined 25 percent over the previous week, after a month-long trend of rising infections. The CDC is reporting 54,911 confirmed cases of the virus globally (CDC, https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html, Accessed 9/7/2022), including 20,733 cases in the U.S.
Preventing the Spread of Mpox
Gay, bisexual, and other men who have sex with men make up the majority of cases in the current mpox outbreak. However, anyone who has been in close, personal contact with someone who has mpox or items that have been in contact with lesions (such as clothing or bedding) (CDC, https://www.cdc.gov/poxvirus/monkeypox/transmission.html, Accessed 9/7/2022) is at risk, regardless of sexual orientation or gender identity.
Health care providers should be alert for patients with rash illness consistent with mpox (CDC, https://www.cdc.gov/poxvirus/monkeypox/clinicians/clinical-recognition.html, Accessed 9/7/2022) and follow the identify, isolate, and inform strategy to prevent further spread. Watch NETEC’s webinar The I’s Have It: Identify, Isolate, and Inform for more information.
WHO Renames Mpox
The WHO has renamed the two variants of mpox. The Congo Basin or Central African clade is now referred to as Clade I; and the West African clade is referred to as Clade II, with subclades IIa and IIb. Clade IIb is the dominant variant in the current multi-country outbreak.
According to the WHO, the change aligns with current best practices for naming viruses and diseases. Newly-identified viruses, related disease, and virus variants should be given names that avoid offending any cultural, social, national, regional, professional, or ethnic groups, and minimize any negative impact on trade, travel, tourism, or animal welfare.
Mpox Testing Guidance
The CDC has released new testing guidance in response to ongoing reports of false positive test results. Laboratory professionals should repeat testing for patients with high Cycle Threshold (or Ct) values (≥34) who do not meet identified epidemiologic risk criteria for mpox.
Currently, testing is only recommended for patients who have a rash consistent with mpox (CDC, https://www.cdc.gov/poxvirus/monkeypox/testing/testing-basics.html, Accessed 9/7/2022). Health care professionals should look at key characteristics for identifying mpox (CDC, https://www.cdc.gov/poxvirus/monkeypox/clinicians/clinical-recognition.html, Accessed 9/7/2022), and view NETEC’s course on mpox specimen collection. To learn more about mpox testing in the lab, listen to the NETEC podcast episode, “Mpox Testing in Your Laboratory.”
About the Author
Athena Plichta, BSN, RN, DTN, a-IPC is a public health nurse and graduate student in the MPH-Epidemiology program at the University of Nebraska Medical Center (UNMC). She is interested in emerging infectious diseases, infectious disease epidemiology and preparedness, infection prevention and control, and biosecurity. She currently works at a local health department in Northern Virginia.
Get Expert Assistance
Ask a NETEC expert a question or request free services for your facility.
Find Resources
Explore special pathogen resources created and curated by NETEC experts.
